Denosumab Versus Bisphosphonates (Alendronate) in GIOP
Status:
Completed
Trial end date:
2020-02-01
Target enrollment:
Participant gender:
Summary
A randomized controlled trial to compare for the efficacy and tolerability of denosumab and
oral alendronate in the management of glucocorticoid induced osteoporosis